Altrova HealthXCNQ:ROVA EBITDA Margin % is -670.54% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 668 Asset Management companies, Altrova Health ranks worse than 95.51% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Altrova Health's EBITDA for the
three
months ended in Mar. 2026 was C$-0.75 Mil. Altrova Health's Revenue for the
three
months ended in Mar. 2026 was C$0.11 Mil. Therefore, Altrova Health's EBITDA margin for the quarter that ended in Mar. 2026 was -670.54%.
Altrova Health (XCNQ:ROVA) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Altrova Health EBITDA Margin % Related Terms
Altrova Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Altrova Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XCNQ:ROVA vs BLK, BX, KKR: EBITDA Margin % Comparison
For the Asset Management subindustry, Altrova Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Altrova Health EBITDA Margin % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Altrova Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Altrova Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Altrova Health (XCNQ:ROVA) has a EBITDA Margin % of -670.54% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Altrova Health and its competitors. According to the industry distribution chart, Altrova Health ranks #638 out of 668 companies in the Asset Management industry, placing it in the top 95.5%.
Is Altrova Health's EBITDA Margin % too high?
Altrova Health's current EBITDA Margin % is -670.54%. Based on the distribution chart, Altrova Health ranks #638 out of 668 companies in the Asset Management industry, which is in the bottom quartile relative to peers.
How does Altrova Health's EBITDA Margin % compare to BLK and BX?
According to the Asset Management industry distribution chart, Altrova Health ranks #638 out of 668 companies for EBITDA Margin %. This places Altrova Health in the lower half of its industry. The industry median EBITDA Margin % is 30.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Asset Management company?
The median EBITDA Margin % among Asset Management companies is 30.12, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Altrova Health and its competitors. For the Asset Management industry, the median EBITDA Margin % is 30.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Altrova Health's current EBITDA Margin % is -670.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altrova Health stock overvalued right now?
Altrova Health (XCNQ:ROVA) has a current EBITDA Margin % of -670.54%. The current EBITDA Margin % is -670.54%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Altrova Health (XCNQ:ROVA), the current EBITDA Margin % is -670.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Altrova Health Inc is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company is focused on supporting multiple products, brands, and growth pathways under one stronger corporate identity, expanding beyond any single product story to create a more durable business. The Company continues to evaluate opportunities to expand its product offerings across the public health and safety sector.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCNQ:ROVA has been successfully added to your 